SARS-CoV-2-IN-95
SARS-CoV-2-IN-95 (Compound 10) is an inhibitor for SARS-CoV-2 PLpro with an IC50 of 0.39 μM. SARS-CoV-2-IN-95 exhibits antiviral activity in mouse SARS-CoV-2-infected model.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- CAS No.: 2817810-96-9
- Formule: C29H36N4OS
- Masse moléculaire:488.69
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Activité biologique
Description
IC50 & Target
IC50: 0.39 μM (SARS-CoV-2 PLpro)
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| A549 | CC50 |
43 μM
Compound: 10; XR8-23
|
Cytotoxicity against human A549 cells harbouring hACE2 assessed as reduction in cell viability by Celltiter-glo luminescent cell viability assay
Cytotoxicity against human A549 cells harbouring hACE2 assessed as reduction in cell viability by Celltiter-glo luminescent cell viability assay
|
[PMID: 39102360] |
Chemical Information
-
CAS No. 2817810-96-9
-
Masse moléculaire 488.69
-
Formule C29H36N4OS
-
SMILES
CC1=CC=C(NC2CNC2)C=C1C(N[C@H](C)C3=CC(C4=CC=C(CNC5CCCC5)S4)=CC=C3)=O
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
Références
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)